Eli Lilly & Co. (NYSE:LLY)

CAPS Rating: 4 out of 5

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.

Recs

0
Player Avatar GMoneyCaps (70.19) Submitted: 12/13/2011 8:08:31 PM : Outperform Start Price: $38.66 LLY Score: -1.45

12/13

Featured Broker Partners


Advertisement